Kirn David bought FDMT
August 19, 2026 · Form 4 insider transaction
Kirn David bought 50,000 shares of 4D Molecular Therapeutics, Inc. at $4.14 per share, a transaction worth $207.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
50,000
Price
$4.14
Total value
$207.0K
InsiderKirn David
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 19, 2026
Filing dateAugust 21, 2026
Shares owned after894,895
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on January 9, 2026.